Guru Ownership Over Time
Guru Analysis for DiaMedica Therapeutics Inc. (DMAC)
DiaMedica Therapeutics Inc. (DMAC), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $29.02 M.
Top institutional holders include Leon Cooperman and Private Capital.
Institutional sentiment is currently Bullish. This is evidenced by a $9.27 M net inflow during the quarter.
Recent activity highlights Private Capital who opened a new position.
| Portfolio Manager | % of portfolio | Activity | Shares | Value | Peroid |
|---|---|---|---|---|---|
| 0.55% | Add 98.2% | 3,269,761 | $17.64 M | Q3 2025 | |
| 0.03% | New Buy | 50,000 | $343,500 | Q3 2025 | |
| 0.00% | New Buy | 27,451 | $188,588 | Q3 2025 |
| Period | Portfolio Manager | Activity | Share change | % change to portfolio |
|---|
| Period | Portfolio Manager | Activity | Share change | % change to portfolio |
|---|
| Period | Portfolio Manager | Activity | Share change | % change to portfolio |
|---|
| Portfolio Manager | Option Type | % of portfolio | Activity | Shares | Value | Period |
|---|
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown(Q3 2025)
Guru Consensus (Q3 2025)
FAQs for DiaMedica Therapeutics Inc. (DMAC)
Top Guru holders include Leon Cooperman ($17.64 M), Private Capital ($343,500), Cliff Asness ($188,588). Collectively, tracked Gurus hold 3.35 M shares.
Based on recent 13F filings, the sentiment is **Positive (Net Buy)**. There was a net inflow of $9.27 M, with 3 Gurus buying and 0 Gurus selling.
No tracked Gurus reduced or sold out of their positions in DMAC during the most recent reported quarter.
Yes, 2 Gurus opened new positions in DMAC, and 1 added to their existing holdings. Total buy value was $9.27 M.